Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Sponsor
Massachusetts Eye and Ear Infirmary (Other)
Overall Status
Recruiting
CT.gov ID
NCT05317390
Collaborator
(none)
1,000
1
2
58.9
17

Study Details

Study Description

Brief Summary

This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: DystoniaNet-based diagnosis of isolated dystonia
N/A

Detailed Description

Isolated dystonia is a movement disorder of unknown pathophysiology, which causes involuntary muscle contractions leading to abnormal, typically patterned, twisting movements and postures. A significant challenge in the clinical management of dystonia is due to the absence of a biomarker and associated 'gold' standard diagnostic test. Currently, the diagnosis of dystonia is guided by clinical evaluations of its symptoms, which lead to a low agreement between clinicians and a high rate of diagnostic inaccuracies. It is estimated that only 5% of patients receive an accurate diagnosis at symptom onset, and the average diagnostic delay extends up to 10.1 years. This study will conduct retrospective and prospective studies to clinically validate the performance of DystoniaNet, a biomarker-based deep learning platform for the diagnosis of isolated dystonia.

The retrospective studies will clinically validate the diagnostic performance of the DystoniaNet algorithm (1) in patients compared to healthy subjects (normative test), and (2) between patients with dystonia and other neurological and non-neurological conditions (differential test).

The prospective randomized study will validate the performance of DystoniaNet algorithm for accurate, objective, and fast diagnosis of dystonia in the actual clinical setting.

This research is expected to advance the DystoniaNet algorithm for dystonia diagnosis into its clinical use for increased accuracy of dystonia diagnosis. Early detection and diagnosis of dystonia will enable its early therapy and improved prognosis, having an overall positive impact on healthcare and patients' quality of life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Diagnostic
Official Title:
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Apr 30, 2027
Anticipated Study Completion Date :
Apr 30, 2027

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Retrospective clinical validation of DystoniaNet

Retrospective studies will (1) clinically validate the diagnostic performance of DystoniaNet compared to a normal neurological state (normative test), and (2) develop and test DystoniaNet extensions in comparison with other neurological and non-neurological conditions (differential test).

Experimental: Prospective clinical validation of DystoniaNet

Prospective randomized studies will validate DystoniaNet performance for accurate, objective, and fast diagnosis of dystonia in the actual clinical setting.

Diagnostic Test: DystoniaNet-based diagnosis of isolated dystonia
DystoniaNet will be used for the diagnosis of dystonia and its differential diagnosis from other neurological and non-neurological disorders mimicking symptoms of dystonia

Outcome Measures

Primary Outcome Measures

  1. Correctness of clinical diagnosis of dystonia using the DystoniaNet algorithm [4 years]

    Correctness of dystonia diagnosis (yes dystonia/no dystonia) will be established using the DystoniaNet machine-learning algorithm

  2. Time of clinical diagnosis of dystonia using the DystoniaNet algorithm [4 years]

    The length of time (in months) from symptom onset to clinical diagnosis will be established using the DystoniaNet machine-learning algorithm

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  1. Males and females of diverse racial and ethnic backgrounds, with age across the lifespan;

  2. Patients will have at least one of the forms of dystonia, including focal dystonia (e.g., laryngeal, cervical, oromandibular, blepharospasm, focal hand, musicians), segmental dystonia, or generalized dystonia;

  3. Patients will have other movement disorders (Parkinson's disease, essential tremor, dyskinesia, myoclonus) and other non-neurological conditions (tic disorders, torticollis, ulnar nerve entrapments, temporomandibular disorders, dysphonia) that mimic dystonic symptoms.

Exclusion criteria:
  1. Patients who are incapable of giving informed consent;

  2. Patients who are unable to undergo brain MRI due to the presence of certain tattoos and ferromagnetic objects in their bodies (e.g., implanted stimulators, surgical clips, prosthesis, artificial heart valve) that cannot be removed or due to pregnancy or breastfeeding at the time of the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts Eye and Ear Infirmary Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts Eye and Ear Infirmary

Investigators

  • Principal Investigator: Kristina Simonyan, MD, PhD, Massachusetts Eye and Ear

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kristina Simonyan, Associate Professor of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear Infirmary
ClinicalTrials.gov Identifier:
NCT05317390
Other Study ID Numbers:
  • 2020P004129
First Posted:
Apr 7, 2022
Last Update Posted:
Aug 12, 2022
Last Verified:
Aug 1, 2022

Study Results

No Results Posted as of Aug 12, 2022